Combination therapy holds promise, however further studies are needed to define optimal treatment strategies
Then theres tirzepatide (Mounjaro, Zepbound), a newer medication that not only targets GLP-1 but also GIP receptors, and studies show it may deliver even greater weight loss results and metabolic benefits
Furthermore, it enhances the validity and reduces potential bias
So, the findings bring up a potentially exciting new possibility: Giving metformin or a GLP-1 to people with asthma to help treat the breathing disorder and any underlying diabetes
Patients should seek immediate medical attention for severe persistent abdominal pain (possible pancreatitis), right upper quadrant pain with fever or jaundice (possible gallbladder disease), or signs of dehydration
Check with your doctor first before taking it with other medications to prevent interaction